Dr. Reddy’s US plant receives FDA observation

Dr.  Reddy’s US plant receives FDA observation

Dr. in Middleburg, New York. The API manufacturing plant of Reddy’s Laboratories has received 3 observations following a US Food and Drug Administration audit. “We have been issued a Form 483 with three comments… will address them comprehensively within the stipulated timeframe. Currently, we do not have any sales from this plant, ”the company informed the stock exchange on Wednesday. However, it did not share details of observations made by the regulator. The company shares gained 1.15%. Closed at the level of 4,498.65. Through Form 483 the USFDA notifies the management of the company whose facility is inspected by its officers for objectionable conditions observed that may constitute violations of the Food Drugs and Cosmetics Act and related Acts.

You have reached your limit for free articles this month.

Membership benefits included

Today’s paper

Get a mobile-friendly version of the article from the newspaper of the day in an easy-to-read list.

unlimited access

Enjoy reading as many articles as you want without any limitations.

Personal recommendations

A select list of articles that match your interests and tastes.

Fast page

Move seamlessly between articles as our pages load instantly.

Dashboard

One-stop-shop to see the latest updates and manage your preferences.

Talk

We inform you about the latest and most important events three times a day.

Support quality journalism.

* Our digital subscription plans currently do not include e-paper, crosswords and print.

Be the first to comment

Leave a Reply

Your email address will not be published.


*